Xiaohua Wu Selected Research

deltonin

4/2015	Deltonin inhibits angiogenesis by regulating VEGFR2 and subsequent signaling pathways in endothelial cells.
3/2013	Deltonin induces apoptosis in MDA‑MB‑231 human breast cancer cells via reactive oxygen species‑mediated mitochondrial dysfunction and ERK/AKT signaling pathways.
1/2011	Deltonin isolated from Dioscorea zingiberensis inhibits cancer cell growth through inducing mitochondrial apoptosis and suppressing Akt and mitogen activated protein kinase signals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaohua Wu Research Topics

Disease

86	Neoplasms (Cancer) 05/2022 - 01/2002
44	Ovarian Neoplasms (Ovarian Cancer) 12/2022 - 03/2007
34	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 08/2011
20	Neoplasm Metastasis (Metastasis) 02/2022 - 08/2005
19	Ovarian Epithelial Carcinoma 07/2022 - 01/2002
18	Carcinoma (Carcinomatosis) 05/2022 - 04/2003
13	Carcinogenesis 11/2021 - 02/2011
11	Lymphatic Metastasis 01/2021 - 05/2013
9	Genomic Instability 12/2021 - 06/2010
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 06/2013
5	Disease Progression 12/2022 - 01/2021
5	Chromosome Aberrations (Chromosome Abnormalities) 05/2021 - 06/2010
5	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2004
5	Temporal Lobe Epilepsy 01/2021 - 10/2016
5	Epilepsy (Aura) 01/2021 - 10/2016
5	Margins of Excision 01/2021 - 05/2013
4	Inflammation (Inflammations) 06/2022 - 01/2006
4	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 05/2007
4	Ascites 09/2020 - 03/2016
4	Infections 08/2014 - 03/2013
3	Anemia 12/2022 - 01/2021
3	Mitochondrial Diseases (Mitochondrial Disease) 11/2020 - 03/2010
3	Stomach Neoplasms (Stomach Cancer) 10/2020 - 01/2015
3	Osteoporosis 12/2019 - 01/2012
3	Pathologic Constriction (Stenosis) 08/2017 - 09/2015
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2016 - 08/2007
3	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2011 - 04/2008
2	Nausea 12/2022 - 01/2021
2	Endometriosis 01/2022 - 11/2020
2	Adenocarcinoma 01/2022 - 01/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 10/2002
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 05/2011
2	Hypoxia (Hypoxemia) 01/2021 - 03/2020
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2021
2	Seizures (Absence Seizure) 01/2021 - 08/2017
2	Residual Neoplasm 08/2020 - 01/2016
2	Body Weight (Weight, Body) 01/2020 - 11/2010

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 06/2022 - 10/2002
18	PlatinumIBA 12/2022 - 04/2013
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2011
13	Cisplatin (Platino)FDA LinkGeneric 03/2021 - 02/2012
12	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2004
10	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2013
8	Messenger RNA (mRNA)IBA 03/2022 - 03/2007
8	Pharmaceutical PreparationsIBA 01/2021 - 04/2011
7	AntigensIBA 12/2020 - 06/2011
6	Biological ProductsIBA 05/2022 - 03/2007
6	Long Noncoding RNAIBA 01/2021 - 01/2016
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2022 - 10/2017
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2021 - 09/2018
4	squamous cell carcinoma-related antigenIBA 01/2021 - 08/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
4	SaponinsIBA 04/2015 - 12/2009
3	Ligases (Synthetase)IBA 05/2022 - 01/2019
3	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 06/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 03/2020
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 03/2021
3	EnzymesIBA 12/2021 - 12/2012
3	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021 - 01/2013
3	CarbohydratesIBA 12/2020 - 01/2018
3	fibrin fragment D (D-dimer)IBA 12/2020 - 01/2020
3	Circular RNAIBA 09/2020 - 01/2020
3	Indicators and Reagents (Reagents)IBA 01/2020 - 03/2007
3	Hormones (Hormone)IBA 05/2017 - 01/2016
3	deltoninIBA 04/2015 - 01/2011
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2015 - 04/2003
2	olaparibIBA 12/2022 - 01/2021
2	niraparibIBA 07/2022 - 01/2020
2	UbiquitinIBA 05/2022 - 01/2019
2	pembrolizumabIBA 01/2022 - 01/2022
2	fluzoparibIBA 01/2022 - 01/2021
2	oxidized low density lipoproteinIBA 12/2021 - 04/2014
2	Histones (Histone)IBA 05/2021 - 01/2016
2	FlavonoidsIBA 05/2021 - 06/2020
2	Mitogen-Activated Protein KinasesIBA 03/2021 - 01/2011
2	RNA (Ribonucleic Acid)IBA 03/2021 - 01/2021
2	Kainic Acid (Kainate)IBA 01/2021 - 08/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2013
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2011
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 01/2011
2	LigandsIBA 01/2021 - 05/2014
2	Fibrinogen (Factor I)FDA Link 12/2020 - 01/2016
2	Tumor Biomarkers (Tumor Markers)IBA 09/2020 - 06/2014
2	TNF Receptor-Associated Factor 4IBA 12/2019 - 01/2017

Therapy/Procedure

32	Therapeutics 01/2022 - 08/2005
22	Drug Therapy (Chemotherapy) 05/2022 - 04/2011
11	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 02/2012
11	Radiotherapy 01/2022 - 05/2013
11	Trachelectomy 01/2022 - 06/2011
10	Hysterectomy 01/2022 - 09/2014
4	Chemoradiotherapy 01/2021 - 07/2016
4	Neoadjuvant Therapy 10/2020 - 02/2012
4	Brachytherapy 12/2017 - 02/2012
3	Conservative Treatment 01/2022 - 02/2012
3	Craniotomy 01/2019 - 07/2016
2	Ostomy 03/2022 - 02/2022
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022 - 01/2021
2	Adjuvant Radiotherapy 01/2022 - 12/2020
2	Immunotherapy 01/2022 - 06/2011
2	Cytoreduction Surgical Procedures 08/2021 - 11/2016